These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20373906)

  • 1. The Adaptive Aerosol Delivery system in a telehealth setting: patient acceptance, performance and feasibility.
    Nikander K; Denyer J; Dodd M; Dyche T; Webb K; Weller P; Stableforth D
    J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S21-7. PubMed ID: 20373906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intelligent nebulizers in the age of the Internet: The I-neb Adaptive Aerosol Delivery (AAD) system.
    Dhand R
    J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):iii-v. PubMed ID: 20373913
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis.
    Denyer J; Prince I; Dixon E; Agent P; Pryor J; Hodson M
    J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S29-36. PubMed ID: 20373907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domiciliary experience of the Target Inhalation Mode (TIM) breathing maneuver in patients with cystic fibrosis.
    Denyer J; Black A; Nikander K; Dyche T; Prince I
    J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S45-54. PubMed ID: 20373909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) system.
    Hardaker LE; Hatley RH
    J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S11-20. PubMed ID: 20373905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Adaptive Aerosol Delivery (AAD) technology: Past, present, and future.
    Denyer J; Dyche T
    J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S1-10. PubMed ID: 20373904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive Aerosol Delivery (AAD) technology.
    Denyer J; Nikander K; Smith NJ
    Expert Opin Drug Deliv; 2004 Nov; 1(1):165-76. PubMed ID: 16296727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New nebulizer technology to monitor adherence and nebulizer performance in cystic fibrosis.
    McCormack P; Southern KW; McNamara PS
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):307-9. PubMed ID: 22856641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis.
    Häussermann S; Winnips C; Edelman J; Kappeler D; Herpich C; Ehlich H; Zanker D; Kietzig C; Sommerer K
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):242-50. PubMed ID: 26669827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol treatment of cystic fibrosis.
    Garcia-Contreras L; Hickey AJ
    Crit Rev Ther Drug Carrier Syst; 2003; 20(5):317-56. PubMed ID: 14959788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Action of a Web-Based Intervention With Health Professional Support to Increase Adherence to Nebulizer Treatments in Adults With Cystic Fibrosis: Qualitative Interview Study.
    Drabble SJ; O'Cathain A; Scott AJ; Arden MA; Keating S; Hutchings M; Maguire C; Wildman M
    J Med Internet Res; 2020 Oct; 22(10):e16782. PubMed ID: 32697197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Affecting the Acceptance of Telehealth Services by Heart Failure Patients: An Integrative Review.
    Woo K; Dowding D
    Telemed J E Health; 2018 Apr; 24(4):292-300. PubMed ID: 28767315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The I-neb Adaptive Aerosol Delivery System enhances delivery of alpha1-antitrypsin with controlled inhalation.
    Geller DE; Kesser KC
    J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):S55-9. PubMed ID: 20373910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled Treprostinil Drug Delivery During Mechanical Ventilation and Spontaneous Breathing Using Two Different Nebulizers.
    Parker DK; Shen S; Zheng J; Ivy DD; Crotwell DN; Hotz JC; DiBlasi RM
    Pediatr Crit Care Med; 2017 Jun; 18(6):e253-e260. PubMed ID: 28441181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung deposition after electronically breath-controlled inhalation and manually triggered conventional inhalation in cystic fibrosis patients.
    Köhler E; Sollich V; Schuster-Wonka R; Jorch G
    J Aerosol Med; 2005; 18(4):386-95. PubMed ID: 16379615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical considerations in aerosol drug delivery.
    Kuhn RJ
    Pharmacotherapy; 2002 Mar; 22(3 Pt 2):80S-85S. PubMed ID: 11898885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrating-mesh nebulizer maintenance by CF patients: Results from a French survey.
    Baravalle-Einaudi M; Dufeu N; Dupont C; Vecellio L; Delaisi B; Carsin A; Dubus JC;
    Pulm Pharmacol Ther; 2017 Jun; 44():57-60. PubMed ID: 28315491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system.
    Geller DE; Rosenfeld M; Waltz DA; Wilmott RW;
    Chest; 2003 Jan; 123(1):28-36. PubMed ID: 12527599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery systems: an in vitro study.
    Van Dyke RE; Nikander K
    Respir Care; 2007 Feb; 52(2):184-90. PubMed ID: 17261207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The function and performance of aqueous aerosol devices for inhalation therapy.
    Carvalho TC; McConville JT
    J Pharm Pharmacol; 2016 May; 68(5):556-78. PubMed ID: 27061412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.